ANI
24 Jan 2023, 12:07 GMT+10
Hyderabad (Telangana) [India], January 24 (ANI): Granules India announced on Tuesday that the US Food and Drug Administration (US FDA) has approved the abbreviated new drug application (ANDA) filed by its US subsidiary -- Granules Pharmaceuticals, Inc (GPI) -- for Amphetamine mixed salts used for treating attention disorder.
Amphetamine is bioequivalent to the reference listed drug product (RLD), Adderall XR extended-release capsules of Takeda Pharmaceuticals. This product will be manufactured at Granules manufacturing facility in Chantilly, Virginia, and is expected to be launched shortly, according to a company statement shared with stock exchanges.
An abbreviated new drug application (ANDA) is an application for a US generic drug approval for an existing licensed medication or approved drug.
Priyanka Chigurupati, Executive Director, GPI, said "We are pleased to receive the approval of Amphetamine Mixed Salts ER Capsules within 10-months of ANDA filing, which is an extended-release dosage form of a controlled substance (C-II)."Mixed salts of single-entity Amphetamine ER Capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD). The company added Granules now have a total of 53 ANDA approvals from US FDA with 51 final approvals and two tentative approvals.
The current annual US market for Amphetamine mixed salts ER capsule product is approximately USD 1.56 billion, according to MAT Nov 2022, IQVIA/IMS Health.
Granules India, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered at Hyderabad with modern facilities. The pharmaceutical company has manufacturing units of the entire value chain - from active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs).
The company has seven manufacturing facilities out of which six are located in India and one in the US. (ANI)Get a daily dose of India Gazette news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to India Gazette.
More InformationNEW YORK, New York - The knee-jerk introduction of trade tariffs by President Donald Trump continues to rattle markets with all the...
FRANKFURT, Germany: Ford announced this week that it will inject up to $4.8 billion into its struggling German unit to stabilize its...
SEATTLE, Washington: Boeing has revamped its employee incentive plan, tying annual bonuses for more than 100,000 workers to overall...
WINNIPEG, Manitoba: Farmers in the U.S. and Canada are bracing for soaring fertilizer prices as trade tensions escalate between the...
NEW YORK, New York - A slightly lower-than-expected CPI reading for February helped U.S. stocks to stabilize after some relentless...
NEW YORK CITY, New York: New York's office market is showing signs of a comeback as major investors, including Blackstone, scout for...
NEW DELHI, India: The United States is pressing India to lower tariffs and increase defense purchases to secure a stronger bilateral...
New Delhi [India], March 14 (ANI): Delhi's Tis Hazari Court on Thursday sentenced a man to life imprisonment for raping and impregnating...
New Delhi [India], March 13 (ANI): A row erupted on Thursday after West Bengal Leader of the Opposition Suvendu Adhikari claimed that...
By Vipul Kashyap New Delhi [India], March 13 (ANI): England batter Harry Brook has been banned from participating in the Indian Premier...
New Delhi [India], March 13 (ANI): India closed out a remarkable campaign at the World Para Athletics Grand Prix 2025, finishing at...
New Delhi [India], March 13 (ANI): External Affairs Minister (EAM) S Jaishankar on Thursday met with a delegation of fishermen from...